Light Mode
$3.33 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.33, $0.24 below the day’s high of $3.57
-2.45 (-42.39%) / 6M
Momentum, market sentiment, and recent alerts
PASG reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -56.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.